Erratum: Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques (Immunogenetics (DOI 10.1007/s00251-011-0566-0));Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques

Immunogenetics

Volumn 64, Issue 2, 2012, Pages 111-121

  Mladinich, Katherine M ^a   Piaskowski, Shari M ^b   Rudersdorf, Richard ^b   Eernisse, Christopher M ^b,c   Weisgrau, Kim L ^b,c   Martins, Mauricio A ^b   Furlott, Jessica R ^b,c   Partidos, Charalambos D ^a   Brewoo, Joseph N ^a   Osorio, Jorge E ^a   Wilson, Nancy A ^b,c   Rakasz, Eva G ^b,c   Watkins, David I ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Dengue; Indian rhesus macaque

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENGUE; DENGUE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALIA; DENGUE VIRUS; MACACA MULATTA;

EID: 84857361848     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-011-0593-x     Document Type: Erratum

References (44)

1. SJ Balsitis KL Williams R Lachica D Flores JL Kyle E Mehlhop, et al. 2010 Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification PLoS Pathog 6 e1000790 20168989 10.1371/journal.ppat.1000790
2. MR Betts JM Brenchley DA Price SC De Rosa DC Douek M Roederer, et al. 2003 Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation J Immunol Methods 281 65 78 14580882 10.1016/S0022-1759(03)00265-5 1:CAS:528:DC%2BD3sXot1Olsrs%3D
3. MR Betts MC Nason SM West SC De Rosa SA Migueles J Abraham, et al. 2006 HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells Blood 107 4781 4789 16467198 10.1182/blood-2005-12-4818 1:CAS:528:DC%2BD28XlvFCgtrg%3D
4. MC Bonaldo MA Martins R Rudersdorf PA Mudd JB Sacha SM Piaskowski, et al. 2010 Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques J Virol 84 3699 3706 20089645 10.1128/JVI.02255-09 1:CAS:528:DC%2BC3cXktFOgur4%3D
5. P Borrow H Lewicki BH Hahn GM Shaw MB Oldstone 1994 Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection J Virol 68 6103 6110 8057491 1:CAS:528:DyaK2cXlsFGmt7w%3D
6. JF Bukowski I Kurane CJ Lai M Bray B Falgout FA Ennis 1989 Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes J Virol 63 5086 5091 2511337 1:STN:280:DyaK3c%2FmsVOksw%3D%3D
7. AN Cline JW Bess MJ Piatak JD Lifson 2005 Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS J Med Primatol 34 303 312 16128925 10.1111/j.1600-0684.2005.00128.x 1:CAS:528:DC%2BD2MXhtVCjtLvK
8. MS Diamond TG Roberts D Edgil B Lu J Ernst E Harris 2000 Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons J Virol 74 4957 4966 10799569 10.1128/JVI.74.11.4957-4966.2000 1:CAS:528:DC%2BD3cXjsVKgtbg%3D
9. T Duangchinda W Dejnirattisai S Vasanawathana W Limpitikul N Tangthawornchaikul P Malasit, et al. 2010 Immunodominant T-cell responses to dengue virus NS3 are associated with DHF Proc Natl Acad Sci USA 107 16922 16927 20837518 10.1073/pnas.1010867107 1:CAS:528:DC%2BC3cXht1Olsb7J
10. SJ Gagnon FA Ennis AL Rothman 1999 Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones J Virol 73 3623 3629 10196254 1:CAS:528:DyaK1MXis1ensrg%3D
11. AP Goncalvez RE Engle M St Claire RH Purcell CJ Lai 2007 Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention Proc Natl Acad Sci USA 104 9422 9427 17517625 10.1073/pnas.0703498104 1:CAS:528:DC%2BD2sXmtlegtb0%3D
12. A Grakoui NH Shoukry DJ Woollard JH Han HL Hanson J Ghrayeb, et al. 2003 HCV persistence and immune evasion in the absence of memory T cell help Science 302 659 662 14576438 10.1126/science.1088774 1:CAS:528:DC%2BD3sXotlWqtLw%3D
13. SB Halstead 1979 In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody J Infect Dis 140 527 533 117061 10.1093/infdis/140.4.527 1:STN:280:DyaL3c%2FntlGisg%3D%3D
14. SB Halstead NT Lan TT Myint TN Shwe A Nisalak S Kalyanarooj, et al. 2002 Dengue hemorrhagic fever in infants: research opportunities ignored Emerg Infect Dis 8 1474 1479 12498666
15. KJ Hasenkrug DM Brooks U Dittmer 1998 Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice J Virol 72 6559 6564 9658100 1:CAS:528:DyaK1cXks1Cjs7s%3D
16. H Horton EP Thomas JA Stucky I Frank Z Moodie Y Huang YL Chiu MJ De McElrath SC Rosa 2007 Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination J Immunol Methods 323 39 54 17451739 10.1016/j.jim.2007.03.002 1:CAS:528:DC%2BD2sXlt1ShtLw%3D
17. AJ Johnson JT Roehrig 1999 New mouse model for dengue virus vaccine testing J Virol 73 783 786 9847388 1:CAS:528:DyaK1cXotFSktLs%3D
18. SH Kaufmann 1988 CD8+ T lymphocytes in intracellular microbial infections Immunol Today 9 168 174 3151440 10.1016/0167-5699(88)91292-3 1:STN:280:DyaL1MznsVKlsQ%3D%3D
19. AM Khan O Miotto EJ Nascimento KN Srinivasan AT Heiny GL Zhang, et al. 2008 Conservation and variability of dengue virus proteins: implications for vaccine design PLoS Negl Trop Dis 2 e272 18698358 10.1371/journal.pntd.0000272
20. I Kurane A Meager FA Ennis 1989 Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity J Exp Med 170 763 775 2475573 10.1084/jem.170.3.763 1:CAS:528:DyaL1MXlsFWrsLk%3D
21. I Kurane MA Brinton AL Samson FA Ennis 1991 Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones J Virol 65 1823 1828 1705990 1:CAS:528:DyaK3MXitVGitLw%3D
22. JL Kyle SJ Balsitis L Zhang PR Beatty E Harris 2008 Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model Virology 380 296 303 18774583 10.1016/j.virol.2008.08.008 1:CAS:528:DC%2BD1cXht1egtbfL
23. DH Libraty LP Acosta V Tallo E Segubre-Mercado A Bautista JA Potts, et al. 2009 A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model PLoS Med 6 e1000171 19859541 10.1371/journal.pmed.1000171
24. PG Livingston I Kurane LC Dai Y Okamoto CJ Lai R Men, et al. 1995 Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities J Immunol 154 1287 1295 7529799 1:CAS:528: DyaK2MXjt1Kku7g%3D
25. A Mathew I Kurane AL Rothman LL Zeng MA Brinton FA Ennis 1996 Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a J Clin Invest 98 1684 1691 8833919 10.1172/JCI118964 1:STN:280:DyaK28vjtVygtQ%3D%3D
26. A Mathew I Kurane S Green HA Stephens DW Vaughn S Kalayanarooj, et al. 1998 Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection J Virol 72 3999 4004 9557687 1:CAS:528:DyaK1cXis1Krtro%3D
27. M Matloubian RJ Concepcion R Ahmed 1994 CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection J Virol 68 8056 8063 7966595 1:CAS:528:DyaK2MXitFyls7w%3D
28. AJ McMichael FM Gotch GR Noble PA Beare 1983 Cytotoxic T-cell immunity to influenza N Engl J Med 309 13 17 6602294 10.1056/NEJM198307073090103 1:STN:280:DyaL3s3hvFWnuw%3D%3D
29. J Mongkolsapaya W Dejnirattisai XN Xu S Vasanawathana N Tangthawornchaikul A Chairunsri, et al. 2003 Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever Nat Med 9 921 927 12808447 10.1038/nm887 1:CAS:528:DC%2BD3sXkvFOjs7s%3D
30. BR Murphy SS Whitehead 2011 Immune response to dengue virus and prospects for a vaccine Annu Rev Immunol 29 587 619 21219187 10.1146/annurev-immunol- 031210-101315 1:CAS:528:DC%2BC3MXltlKnsLs%3D
31. AL Rothman FA Ennis 1999 Immunopathogenesis of Dengue hemorrhagic fever Virology 257 1 6 10208914 10.1006/viro.1999.9656 1:CAS:528:DyaK1MXisVahsbw%3D
32. AL Rothman S Green DH Libraty FA Ennis 2005 Dengue: translating scientific progress into workable solutions Expert Rev Anti Infect Ther 3 689 692 16207158 10.1586/14787210.3.5.689
33. RA Seder PA Darrah M Roederer 2008 T-cell quality in memory and protection: implications for vaccine design Nat Rev Immunol 8 247 258 18323851 10.1038/nri2274 1:CAS:528:DC%2BD1cXjs1antLk%3D
34. DS Shepard L Coudeville YA Halasa B Zambrano GH Dayan 2011 Economic impact of dengue illness in the Americas Am J Trop Med Hyg 84 200 207 21292885 10.4269/ajtmh.2011.10-0503
35. S Shresta JL Kyle HM Snider M Basavapatna PR Beatty E Harris 2004 Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical J Virol 78 2701 2710 14990690 10.1128/JVI.78.6.2701-2710.2004 1:CAS:528:DC%2BD2cXitlSnt74%3D
36. DW Vaughn S Green S Kalayanarooj BL Innis S Nimmannitya S Suntayakorn, et al. 2000 Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity J Infect Dis 181 2 9 10608744 10.1086/315215 1:STN:280:DC%2BD3c%2Fos12qsw%3D%3D
37. H Veiga-Fernandes U Walter C Bourgeois A McLean B Rocha 2000 Response of naive and memory CD8+ T cells to antigen stimulation in vivo Nat Immunol 1 47 53 10881174 10.1038/76907 1:CAS:528:DC%2BD3cXls1yqs7w%3D
38. HW Virgin EJ Wherry R Ahmed 2009 Redefining chronic viral infection Cell 138 30 50 19596234 10.1016/j.cell.2009.06.036 1:CAS:528:DC%2BD1MXps1ygur4%3D
39. DP Webster J Farrar S Rowland-Jones 2009 Progress towards a dengue vaccine Lancet Infect Dis 9 678 687 19850226 10.1016/S1473-3099(09)70254-3
40. NA Wilson J Reed GS Napoe S Piaskowski A Szymanski J Furlott, et al. 2006 Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239 J Virol 80 5875 5885 16731926 10.1128/JVI.00171-06 1:CAS:528:DC%2BD28XlsFWmsrk%3D
41. NA Wilson BF Keele JS Reed SM Piaskowski CE MacNair AJ Bett, et al. 2009 Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge J Virol 83 6508 6521 19403685 10.1128/JVI.00272-09 1:CAS:528:DC%2BD1MXnvF2lt7c%3D
42. World Health Organization (2011) Dengue and dengue haemorrhagic fever. World Health Organization. http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed 10 June 2011
43. LE Yauch RM Zellweger MF Kotturi A Qutubuddin J Sidney B Peters, et al. 2009 A protective role for dengue virus-specific CD8+ T cells J Immunol 182 4865 4873 19342665 10.4049/jimmunol.0801974 1:CAS:528:DC%2BD1MXjvFOju78%3D
44. LE Yauch TR Prestwood MM May MM Morar RM Zellweger B Peters, et al. 2010 CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination J Immunol 185 5405 5416 20870934 10.4049/jimmunol.1001709 1:CAS:528: DC%2BC3cXhtlWhsrfM